THE ‘PAUSE’ ON THE JOHNSON & JOHNSON CORONAVIRUS VACCINE reveals one systemic flaw plaguing the FDA: an overabundance of caution.

Maybe Americans will finally realize the extent to which federal bureaucracy routinely stops potentially life-saving innovation in its tracks.